Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors

This study is testing transcranial magnetic stimulation (TMS) — a non-invasive brain stimulation technique — for treating nerve pain caused by chemotherapy (also called chemotherapy-induced peripheral neuropathy, or CIPN). The pain can affect hands and feet and is a common and difficult-to-treat side effect of certain cancer treatments. **You may be eligible if...** - You are a woman aged 18 or older with a confirmed diagnosis of breast or gynecologic cancer - You developed neuropathic pain during or shortly after receiving platinum-based drugs, taxanes, or vinca alkaloids - Your pain score is 4 or above on a 0–10 scale, and your neuropathic pain score is 3 or above on the DN-4 questionnaire - The pain has persisted despite current treatment **You may NOT be eligible if...** - You have a pacemaker, metal implants in or near the head, or a history of seizures (which would make TMS unsafe) - You are pregnant - You have significant cognitive impairment - Your pain started more than one month after chemotherapy ended Talk to your doctor to see if this trial is right for you.